N-(5-chloro-2-methylphenyl)-2-[2-oxo-5-(pyrrolidine-1-sulfonyl)-1,2 -dihydropyridin-1-yl]acetamide, get quote
![7491-74-9 | Piracetam | 2-Oxo-1-pyrrolidineacetamide; (2-Oxopyrrolidino) acetamide; 2-(2-Oxopyrrolidin-1-yl)acetamide; Avigilen; Axonyl; Cerebroforte; Piramem; Pyracetam; UCB 6215; | C₆H₁₀N₂O₂ | TRC 7491-74-9 | Piracetam | 2-Oxo-1-pyrrolidineacetamide; (2-Oxopyrrolidino) acetamide; 2-(2-Oxopyrrolidin-1-yl)acetamide; Avigilen; Axonyl; Cerebroforte; Piramem; Pyracetam; UCB 6215; | C₆H₁₀N₂O₂ | TRC](https://www.trc-canada.com/prod-img/P500800.png)
7491-74-9 | Piracetam | 2-Oxo-1-pyrrolidineacetamide; (2-Oxopyrrolidino) acetamide; 2-(2-Oxopyrrolidin-1-yl)acetamide; Avigilen; Axonyl; Cerebroforte; Piramem; Pyracetam; UCB 6215; | C₆H₁₀N₂O₂ | TRC
![Characterization and Crystal Nucleation Kinetics of a New Metastable Polymorph of Piracetam in Alcoholic Solvents | Crystal Growth & Design Characterization and Crystal Nucleation Kinetics of a New Metastable Polymorph of Piracetam in Alcoholic Solvents | Crystal Growth & Design](https://pubs.acs.org/cms/10.1021/acs.cgd.1c01421/asset/images/medium/cg1c01421_0001.gif)
Characterization and Crystal Nucleation Kinetics of a New Metastable Polymorph of Piracetam in Alcoholic Solvents | Crystal Growth & Design
![Anticonvulsant agent 1 (4-(2,2-Difluoroethenyl)-α-ethyl-2-oxo-1- pyrrolidineacetamide) | MedChemExpress Anticonvulsant agent 1 (4-(2,2-Difluoroethenyl)-α-ethyl-2-oxo-1- pyrrolidineacetamide) | MedChemExpress](https://file.medchemexpress.com/product_pic/hy-u00348.gif)
Anticonvulsant agent 1 (4-(2,2-Difluoroethenyl)-α-ethyl-2-oxo-1- pyrrolidineacetamide) | MedChemExpress
![US7902380B2 - Process for the preparation of (S)-alpha-ethyl-2-oxo-1- pyrrolidineacetamide and (R)-alpha-ethyl-2-oxo-pyrrolidineacetamide - Google Patents US7902380B2 - Process for the preparation of (S)-alpha-ethyl-2-oxo-1- pyrrolidineacetamide and (R)-alpha-ethyl-2-oxo-pyrrolidineacetamide - Google Patents](https://patentimages.storage.googleapis.com/3a/3c/00/5f122d4723663f/US07902380-20110308-C00004.png)
US7902380B2 - Process for the preparation of (S)-alpha-ethyl-2-oxo-1- pyrrolidineacetamide and (R)-alpha-ethyl-2-oxo-pyrrolidineacetamide - Google Patents
![1 H NMR of 2-(4-methoxyphenyl)-2-oxo-N-(1-phenylethyl)acetamide (3p). | Download High-Resolution Scientific Diagram 1 H NMR of 2-(4-methoxyphenyl)-2-oxo-N-(1-phenylethyl)acetamide (3p). | Download High-Resolution Scientific Diagram](https://www.researchgate.net/publication/51905581/figure/fig1/AS:394083743879169@1470968294157/1-H-NMR-of-2-4-methoxyphenyl-2-oxo-N-1-phenylethylacetamide-3p.png)
1 H NMR of 2-(4-methoxyphenyl)-2-oxo-N-(1-phenylethyl)acetamide (3p). | Download High-Resolution Scientific Diagram
![La Estructura 3d De Piracetam (que Se Vende Bajo Muchas Marcas) Es Una Droga Nootrópica En El Grupo De Los Racetams, Con El Nombre Químico De 2-oxo -1-pirrolidina Acetamida. Fotos, Retratos, Imágenes Y La Estructura 3d De Piracetam (que Se Vende Bajo Muchas Marcas) Es Una Droga Nootrópica En El Grupo De Los Racetams, Con El Nombre Químico De 2-oxo -1-pirrolidina Acetamida. Fotos, Retratos, Imágenes Y](https://previews.123rf.com/images/lculig/lculig1701/lculig170100184/69294082-la-estructura-3d-de-piracetam-que-se-vende-bajo-muchas-marcas-es-una-droga-nootr%C3%B3pica-en-el-grupo-de.jpg)
La Estructura 3d De Piracetam (que Se Vende Bajo Muchas Marcas) Es Una Droga Nootrópica En El Grupo De Los Racetams, Con El Nombre Químico De 2-oxo -1-pirrolidina Acetamida. Fotos, Retratos, Imágenes Y
![Download PDF | Developmental Outcome of Levetiracetam, Its Major Metabolite in Humans, 2-Pyrrolidinone N-Butyric Acid, and Its Enantiomer (R)-α -ethyl- oxo-pyrrolidine Acetamide in a Mouse Model of Teratogenicity Download PDF | Developmental Outcome of Levetiracetam, Its Major Metabolite in Humans, 2-Pyrrolidinone N-Butyric Acid, and Its Enantiomer (R)-α -ethyl- oxo-pyrrolidine Acetamide in a Mouse Model of Teratogenicity](https://www.researchgate.net/profile/Richard-Finnell/publication/9079048/figure/fig1/AS:267463032045574@1440779564129/Chemical-structures-of-levetiracetam-LEV-its-enantiomer-R-a-ethyl-oxo-pyrrolidine_Q320.jpg)
Download PDF | Developmental Outcome of Levetiracetam, Its Major Metabolite in Humans, 2-Pyrrolidinone N-Butyric Acid, and Its Enantiomer (R)-α -ethyl- oxo-pyrrolidine Acetamide in a Mouse Model of Teratogenicity
Analytics for US Patent No. 6969770, 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
2-[3-(4-methylphenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-4-yl]-N-[4-( pyrrolidine-1-sulfonyl)phenyl]acetamide, get quote
![103765-01-1 | (R)-Levetiracetam | (αR)-α-Ethyl-2-oxo-1-pyrrolidineacetamide; (R)-α-ethyl-2-oxo-1-pyrrolidineacetamide; (2R)-2-(2-Oxo-pyrrolidin-1-yl)butanamide; UCB-L 060; Levetiracetam EP Impurity D | C₈H₁₄N₂O₂ | TRC 103765-01-1 | (R)-Levetiracetam | (αR)-α-Ethyl-2-oxo-1-pyrrolidineacetamide; (R)-α-ethyl-2-oxo-1-pyrrolidineacetamide; (2R)-2-(2-Oxo-pyrrolidin-1-yl)butanamide; UCB-L 060; Levetiracetam EP Impurity D | C₈H₁₄N₂O₂ | TRC](https://www.trc-canada.com/prod-img/L331505.png)